Treatment of depression in HIV positive individuals: a critical review.
The primary goal of this paper is to provide a critical review of the literature on treatment of depression in HIV/AIDS. There is a substantial research literature documenting the efficacy of conventional antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs), novel agents such as dehydroepiandrosterone, psychostimulants and some psychotherapies, particularly interpersonal and group psychotherapy for the treatment of depression in HIV. However, lack of comparative studies makes it difficult to draw a firm consensus regarding the best course of treatment. In devising a treatment plan, clinicians should take into account stage of HIV illness, co-morbid illnesses such as Hepatitis B and C, the potential for drug interactions with antiretroviral and other medications used to treat HIV and patient preference.
Ferrando
Stephen J
SJ
Department of Psychiatry, The New York-Presbyterian Hospital, Weill Medical College of Cornell University, New York, USA.
Freyberg
Zachary
Z
D000928:Antidepressive Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D015897:Comorbidity; D003865:Major Depressive Disorder / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy*; D015658:HIV Infections / Q000453:epidemiology / Q000523:psychology*; D006509:Hepatitis B / Q000453:epidemiology; D006526:Hepatitis C / Q000453:epidemiology; D006801:Humans; D011613:Psychotherapy / Q000379:methods
D000928:Antidepressive Agents